Hepatocellular carcinoma

37,741views

Hepatocellular carcinoma

GI system

GI system

Anatomy of the gastrointestinal organs of the pelvis and perineum
Anatomy of the oral cavity (dentistry)
Anatomy of the pharynx and esophagus
Anatomy of the anterolateral abdominal wall
Anatomy of the abdominal viscera: Blood supply of the foregut, midgut and hindgut
Anatomy of the abdominal viscera: Esophagus and stomach
Anatomy of the abdominal viscera: Small intestine
Anatomy of the abdominal viscera: Large intestine
Anatomy of the abdominal viscera: Pancreas and spleen
Anatomy clinical correlates: Anterior and posterior abdominal wall
Abdominal quadrants, regions and planes
Development of the digestive system and body cavities
Development of the gastrointestinal system
Development of the teeth
Development of the tongue
Gallbladder histology
Esophagus histology
Stomach histology
Small intestine histology
Colon histology
Liver histology
Pancreas histology
Gastrointestinal system anatomy and physiology
Anatomy and physiology of the teeth
Liver anatomy and physiology
Escherichia coli
Salmonella (non-typhoidal)
Yersinia enterocolitica
Clostridium difficile (Pseudomembranous colitis)
Enterobacter
Salmonella typhi (typhoid fever)
Clostridium perfringens
Vibrio cholerae (Cholera)
Shigella
Norovirus
Bacillus cereus (Food poisoning)
Campylobacter jejuni
Bacteroides fragilis
Rotavirus
Enteric nervous system
Esophageal motility
Gastric motility
Gastrointestinal hormones
Chewing and swallowing
Carbohydrates and sugars
Fats and lipids
Proteins
Vitamins and minerals
Intestinal fluid balance
Pancreatic secretion
Bile secretion and enterohepatic circulation
Prebiotics and probiotics
Cleft lip and palate
Sialadenitis
Parotitis
Oral candidiasis
Aphthous ulcers
Ludwig angina
Warthin tumor
Oral cancer
Dental caries disease
Dental abscess
Gingivitis and periodontitis
Temporomandibular joint dysfunction
Nasal, oral and pharyngeal diseases: Pathology review
Esophageal disorders: Pathology review
Esophageal web
Esophagitis: Clinical
Barrett esophagus
Achalasia
Zenker diverticulum
Diffuse esophageal spasm
Esophageal cancer
Esophageal disorders: Clinical
Boerhaave syndrome
Plummer-Vinson syndrome
Tracheoesophageal fistula
Mallory-Weiss syndrome
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastroesophageal reflux disease (GERD)
Peptic ulcer
Helicobacter pylori
Gastritis
Peptic ulcers and stomach cancer: Clinical
Pyloric stenosis
Zollinger-Ellison syndrome
Gastric dumping syndrome
Gastroparesis
Gastric cancer
Gastroenteritis
Small bowel bacterial overgrowth syndrome
Irritable bowel syndrome
Celiac disease
Small bowel ischemia and infarction
Tropical sprue
Short bowel syndrome (NORD)
Malabsorption syndromes: Pathology review
Malabsorption: Clinical
Zinc deficiency and protein-energy malnutrition: Pathology review
Whipple's disease
Appendicitis: Pathology review
Appendicitis
Appendicitis: Clinical
Lactose intolerance
Protein losing enteropathy
Microscopic colitis
Inflammatory bowel disease: Pathology review
Crohn disease
Ulcerative colitis
Inflammatory bowel disease: Clinical
Bowel obstruction
Bowel obstruction: Clinical
Volvulus
Familial adenomatous polyposis
Juvenile polyposis syndrome
Gardner syndrome
Colorectal polyps and cancer: Pathology review
Colorectal polyps
Colorectal cancer
Colorectal cancer: Clinical
Peutz-Jeghers syndrome
Diverticulosis and diverticulitis
Diverticular disease: Pathology review
Diverticular disease: Clinical
Intestinal adhesions
Ischemic colitis
Peritonitis
Pneumoperitoneum
Cyclic vomiting syndrome
Abdominal hernias
Femoral hernia
Inguinal hernia
Hernias: Clinical
Congenital gastrointestinal disorders: Pathology review
Congenital diaphragmatic hernia
Imperforate anus
Gastroschisis
Omphalocele
Meckel diverticulum
Intestinal atresia
Hirschsprung disease
Intestinal malrotation
Necrotizing enterocolitis
Intussusception
Anal conditions: Clinical
Anal fissure
Anal fistula
Hemorrhoid
Rectal prolapse
Carcinoid syndrome
Crigler-Najjar syndrome
Biliary atresia
Gilbert's syndrome
Dubin-Johnson syndrome
Rotor syndrome
Jaundice: Pathology review
Jaundice
Cirrhosis
Cirrhosis: Pathology review
Cirrhosis: Clinical
Portal hypertension
Hepatic encephalopathy
Hemochromatosis
Wilson disease
Budd-Chiari syndrome
Non-alcoholic fatty liver disease
Cholestatic liver disease
Hepatocellular adenoma
Alcohol-associated liver disease
Alpha 1-antitrypsin deficiency
Primary biliary cholangitis
Viral hepatitis
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Viral hepatitis: Pathology review
Viral hepatitis: Clinical
Autoimmune hepatitis
Primary sclerosing cholangitis
Neonatal hepatitis
Reye syndrome
Benign liver tumors
Hepatocellular carcinoma
Gallbladder disorders: Pathology review
Gallstones
Gallstone ileus
Biliary colic
Acute cholecystitis
Ascending cholangitis
Chronic cholecystitis
Gallbladder carcinoma
Gallbladder disorders: Clinical
Cholangiocarcinoma
Pancreatic pseudocyst
Acute pancreatitis
Chronic pancreatitis
Pancreatitis: Clinical
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Pancreatitis: Pathology review
Abdominal trauma: Clinical
Gastrointestinal bleeding: Pathology review
Gastrointestinal bleeding: Clinical
Pediatric gastrointestinal bleeding: Clinical
Abdominal pain: Clinical
Disorders of carbohydrate metabolism: Pathology review
Glycogen storage disorders: Pathology review
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Environmental and chemical toxicities: Pathology review
Medication overdoses and toxicities: Pathology review
Laxatives and cathartics
Antidiarrheals
Acid reducing medications

Transcript

Watch video only

Content Reviewers

As opposed to benign hepatic tumors, malignant hepatic tumors are cancerous, very severe, and are actually now the third leading cause of cancer deaths worldwide.

With these malignant liver cells or hepatocytes, just like malignant cells in other cancers, they develop some mutation that causes them to replicate at way higher rates and form these masses of cells that continue to grow and potentially spread to other tissues.

This would be a primary hepatic tumor, since it starts in the liver. It’s totally possible, though, for liver tumor to develop as a metastasis from another primary cancer, in which case it would not be hepatocellular carcinoma, but a carcinoma from somewhere else, and this is actually more common than primary liver tumors themselves.

The most common sources of the tumor cells that got to the liver but started somewhere else are the colon, pancreas, lung and breast.

What exactly causes the mutation in the hepatocyte though?

Well the mechanism isn’t fully understood and can probably be caused by a lot of different things, most importantly though, things that put the liver in a constant cycle of damage and repair are the biggest culprits.

If the liver cells are constantly being forced to repair, this raises the chances of genetic mistakes or mutations, potentially leading to carcinogenesis or development of cancer cells.

Examples might be any disease that leads to cirrhosis and scarring of the liver tissue, which can include alcoholic hepatitis and cirrhosis, hereditary hemochromatosis, primary biliary cirrhosis, alpha-1 antitrypsin deficiency, and others.

The most common risk factor, the ones that have been linked the most with hepatocellular carcinoma are the hepatitis B and hepatitis C viruses, both of which can become chronic or long-lasting.

In this case, these cells are at greater risk because of the constant state of infection and immune cell attack, leading to constant damage and repair.

HBV is particularly problematic because of how the virus replicates; the HBV virus is a DNA virus that integrates into the hepatocyte’s DNA, which, although not completely understood, is thought to either directly disrupt regulation of cell growth and replication, leading to carcinoma, or alternatively cause some indirect effect that later leads to unchecked cell growth and replication.

One interesting risk factor, is exposure to aflatoxins.

Aflatoxins are highly toxic chemicals produced by certain aspergillus molds that can be found in certain foods when they start to decay, like grains, peanuts, and vegetables.

As foods that have this type of mold are eaten, aflatoxins are also eaten, and then they’re absorbed in the small intestine and sent to the liver for metabolizing.

The most potent type of aflatoxin thought to be involved in carcinogenesis is aflatoxin B1, and when it gets to the liver, it’s metabolized to aflatoxin B1 8,9 epoxide.

And now this guy can bind right to DNA, called a DNA adduct.

This interaction leads to mutations in the p53 tumor suppressor gene, which usually when it’s functioning right, stops the formation of tumors, so if it becomes mutated and dysfunctional, tumor formation and carcinogenesis might follow.

Because most patients with hepatocellular carcinoma also have cirrhosis, the hepatocellular carcinoma can be hard to spot.